Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Congratulations to the NEW Dr. Elisabeth Prevete!
On successfully defending her PhD thesis ‘Mental Effects and Potential Therapeutic Use of Kratom/Mitragynine!’ This project was a joint venture between Maastricht University and Sapienza University of Rome. This is Elisabeth’s SECOND doctorate, she now holds an MD and a PhD! Congrats once again Elisbath on a great accomplishment!
Watch the defense here!
Congratulations to the NEW Dr. Eline C. H. M. Haijen!
After successfully defending her PhD thesis entitled: “Exploring the Adult ADHD Treatment Landscape: From Current Practices to Psychedelic Microdosing and Novel Screening Approaches.” In her thesis, she looks at novel approaches of treating ADHD with LSD microdosing.
Watch the defense here!Congratulations to Lilian Kloft-Heller for being awarded the Collaborative Innovative Projects grant
From The Science Committee of the Faculty of Law for her research titled "Effects of Intoxication on Legal Decision-Making in Suspects: Developing Experimental Tools Using Virtual Reality"
Across two studies, Lilian will assess how intoxicated suspects make decisions on their rights and strategies throughout the custodial process. One study will be a field study in which self-intoxicated participants (alcohol) will take part. This study will be conducted in a bar or at a festival. The second study is a lab experiment to examine effects of acute cannabis intoxication on suspect decision-making.
Meet our Department!
The scientists in our lab come from many countries and backgrounds, all with highly unique research abilities. Come meet the people that make up the Psychopharmacology Department.
Learn MoreParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Dr. Malin Vedøy Uthaug
Ayahuasca, 5-MeO-DMT, Consciousness
I am an altered states of consciousness researcher from Norway and one of the world leading experts on 5-MeO-DMT.
Iva Totomanova, MSc
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
Sarah Roche, MSc
Psilocybin, Sustainability, Environment
My PhD research focuses on psychedelic drugs as a tool to investigate the cognitive mechanisms underlying changes in sustainable behavior.
Prof. Arjan Blokland
Cognition, Learning & Memory, Acetylcholine
I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.
Zain Gangaram, MSc
My research is multifaceted and is based on an RDoC model for Reactive Aggression (RA).
Dr. Lilian Kloft
Cognition, Drugs, False Memory
I am a postdoctoral researcher in the fields of psychopharmacology and forensic psychology with an international education from various high-class universities.
Zeus Tipado, MSc
My neuroscience research is focused on perceptual experiences of psychedelics, specifically visual experiences while under DMT.
Dr. Rudy Schreiber
CNS Drug Discovery, Research Domain Criteria
I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies
Pablo Mallaroni, MSc
fMRI/MRS, Idiosyncracy, Psychedelics
I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
Psychedelic Research
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
ego dissolution, cognitive, Ayahuasca
→
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach
→
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
→
Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
vision, retinofugal, tripping, hallucinations, visual, Psychedelics
→
Cannabis Research
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Cognition and motor control as a function of 9-THC concentration in serum and oral fluid: Limits of impairment
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.